Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human SAD study of Daridorexant
NCT02919319Phase 1Completed
- Sponsor
- Idorsia
- Start
- Feb 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of daridorexant in Insomnia (5 arms), sponsored by Idorsia. Primary endpoint: Treatment-emergent adverse events and serious adverse events at Day 8. Started Feb 2015; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02919319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02919319.